Interview with Tomas Kramar, SpectraCure’s board member!

With over 40 years of experience in the industry, including prominent roles as CEO of Siemens Healthineers and CEO of Siemens Healthcare Diagnostics, Tomas Kramar has an impressive career in life science. His decision to join SpectraCure’s board reflects his belief that the company has the potential to offer an exciting and promising solution for prostate cancer treatment in the future.

Do you want to learn more about Tomas Kramar and hear what he considers unique about SpectraCure? Don’t miss the interview!

Play Video